THE LANGUAGE OF PEPTIDE RESEARCH
Peptide glossary
Start with a word. Follow it into the research.
54 terms
A
Absorption
The process by which material from an administered preparation enters the body. The collagen trial examines the appearance of amino acids in blood after ingestion.[1]
Read definition and research contextAdverse event
An unfavorable medical occurrence recorded during a study, with causation assessed separately. The eye trial tabulates events and their relationship to study treatment.[1]
Read definition and research contextAmino acid
One of the molecular units that make up proteins and peptides. The collagen absorption paper discusses glycine, proline and hydroxyproline as amino-acid components of collagen.[1]
Read definition and research contextArea under the curve (AUC)
A summary of concentration across a span of time. In the BPC-157 paper, AUC is the area beneath the plasma concentration-versus-time curve.[1]
Read definition and research contextB
Baseline
The starting measurement used for comparison with later observations. The STEP 1 extension reports participant characteristics and changes relative to specified study time points.[1]
Read definition and research contextBioavailability
The extent to which an administered substance reaches the systemic circulation. The BPC-157 paper estimates absolute bioavailability by comparing dose-adjusted intramuscular and intravenous exposure.[1]
Read definition and research contextBiomarker
A measurable biological characteristic used to study a process or response. The tirzepatide analysis measures blood lipoprotein-related biomarkers.[1]
Read definition and research contextBiomechanical testing
Testing a biological tissue's mechanical behavior. The Achilles repair paper measures the maximum load a repaired rat tendon withstands before failure.[1]
Read definition and research contextBlinding
Keeping specified people in a study unaware of which intervention participants receive. A useful report identifies who was blinded and how.[1]
Read definition and research contextC
Case series
A description of a group of patients with a shared treatment or condition. The BPC-157 knee report describes treated patients without a randomized control group.[1]
Read definition and research contextCollagen
A structural protein found in connective tissue. The collagen absorption paper describes it as an important component of bone, tendon, ligament and cartilage.[1]
Read definition and research contextControl group
The group used as a comparison for the intervention. The Achilles experiment includes a vehicle-treated control group alongside peptide-treated groups.[1]
Read definition and research contextE
Endotoxin
A bacterial toxin contaminant evaluated separately from viable microbes in the semaglutide product-testing study.[1]
Read definition and research contextEndpoint
The specified outcome a study evaluates. The eye trial defines its primary endpoint as complete healing of the persistent corneal epithelial defect at the designated visit.[1]
Read definition and research contextExtracellular matrix
The material surrounding cells in a tissue. The tendon-cell paper describes a matrix containing collagen and glycoproteins around tendon fibroblasts.[1]
Read definition and research contextF
Fibroblast
A connective-tissue cell involved in producing extracellular matrix. The tendon paper describes fibroblasts making collagen and other matrix components during repair.[1]
Read definition and research contextFormulation
The prepared form of a substance used in a study. The RGN-259 trial, for example, evaluates thymosin β4 in an ophthalmic solution.[1]
Read definition and research contextG
Glucagon-like peptide-1 (GLP-1)
The peptide signal whose receptor is targeted by GLP-1 receptor agonists. The STEP 1 extension describes semaglutide as a GLP-1 analogue.[1]
Read definition and research contextGlucose-dependent insulinotropic peptide (GIP)
A peptide signal discussed in the tirzepatide paper in relation to its receptor and metabolic effects. Tirzepatide is described as acting at both GIP and GLP-1 receptors.[1]
Read definition and research contextGrowth hormone
A peptide hormone released from the anterior pituitary. The tendon-cell paper describes growth hormone acting through cell-surface receptors and downstream signaling.[1]
Read definition and research contextGrowth hormone secretagogue
A substance that stimulates growth hormone release. The ipamorelin study examines this action by measuring GH concentrations after administration.[1]
Read definition and research contextGrowth hormone–releasing hormone (GHRH)
A hormone that stimulates growth hormone release. The CJC-1295 paper studies a long-acting analogue of GHRH.[1]
Read definition and research contextH
Half-life
The time taken for a measured drug concentration to decrease by half during the specified decline phase. The BPC-157 paper reports an elimination half-life for the parent peptide.[1]
Read definition and research contextHistology
The microscopic study of tissue structure. In the rat Achilles paper, histological evaluation examines stained sections of healing tendons.[1]
Read definition and research contextHydrolyzed collagen
Collagen processed into smaller peptide fragments by hydrolysis. The cited trial compares collagen preparations that differ in enzymatic processing.[1]
Read definition and research contextI
Immunogenicity
The tendency of a therapeutic substance to provoke an immune response against itself. FDA uses this definition for protein therapeutics.[1]
Read definition and research contextIn vitro
Studied outside a living organism, for example in cultured cells. The BPC-157 tendon paper investigates isolated rat fibroblasts grown in laboratory culture.[1]
Read definition and research contextIn vivo
Studied within a living organism. The BPC-157 pharmacokinetic paper uses in vivo for processes occurring after administration in animals.[1]
Read definition and research contextInsulin-like growth factor 1 (IGF-1)
A growth factor measured alongside growth hormone in the CJC-1295 study. The paper uses the equivalent spelling IGF-I.[1]
Read definition and research contextIntra-articular
Administered within a joint. In the BPC-157 knee report, the term describes injections into the knee.[1]
Read definition and research contextIntramuscular
Administered into muscle. The BPC-157 pharmacokinetic study abbreviates intramuscular administration as IM.[1]
Read definition and research contextIntravenous
Administered into a vein. The BPC-157 pharmacokinetic paper abbreviates this route as IV.[1]
Read definition and research contextM
Metabolism
The chemical transformation of a substance in the body. The BPC-157 study investigates breakdown of the parent peptide into smaller fragments and amino acids.[1]
Read definition and research contextO
Oral
Taken through the mouth. In the collagen absorption trial, oral administration means participants consumed the study preparation as a drink.[1]
Read definition and research contextP
Patient-reported outcome
An outcome reported by the participant, such as their experience of pain. The knee study asked treated patients about their knee symptoms.[1]
Read definition and research contextPeak concentration (Cmax)
The peak measured concentration of a drug in plasma. The BPC-157 paper labels this quantity Cmax.[1]
Read definition and research contextPentadecapeptide
A peptide containing fifteen amino-acid units. The tendon-cell paper uses this term for the BPC-157 fragment.[1]
Read definition and research contextPeptide
A molecule made from a sequence of linked amino-acid units. In the BPC-157 research, the sequence identifies the peptide being tested.[1]
Read definition and research contextPharmacodynamics
The measured biological response to a drug and its relationship to exposure. The ipamorelin paper models GH release in relation to ipamorelin concentrations.[1]
Read definition and research contextPharmacokinetics
The study of a substance's concentrations and movement through the body over time. The BPC-157 paper examines absorption, distribution, metabolism and excretion in rats and dogs.[1]
Read definition and research contextPlacebo
A comparison preparation without the active intervention being tested, often designed to resemble it.[1]
Read definition and research contextPreclinical
Research used to investigate a potential treatment before establishing its clinical use in people. The BPC-157 pharmacokinetic paper describes its animal and laboratory work as preclinical.[1]
Read definition and research contextPurity
An analytical measure of the intended substance relative to other material detected by the test. The online semaglutide study reports purity separately from drug content.[1]
Read definition and research contextR
Randomized controlled trial
A study that uses a chance-based allocation process to assign participants to comparison groups.[1]
Read definition and research contextReceptor
A molecular target through which a signal can act on a cell. The tendon-cell paper describes growth hormone binding to its receptor on the cell membrane and activating intracellular signaling.[1]
Read definition and research contextReceptor agonist
A substance that activates a receptor. In the tirzepatide paper, agonism refers to activity at the receptors for GIP and GLP-1.[1]
Read definition and research contextRetrospective study
A study that looks back at events or treatment that have already occurred. The knee-pain paper describes a retrospective chart review followed by patient contact.[1]
Read definition and research contextRoute of administration
The way a preparation is delivered to the body. The BPC-157 pharmacokinetic study distinguishes intravenous administration from intramuscular administration.[1]
Read definition and research contextS
Sterility
Absence of viable microorganisms. The semaglutide product study evaluated microbiological contamination separately from chemical analysis.[1]
Read definition and research contextSubcutaneous
Administered beneath the skin. The STEP 1 report uses subcutaneous, abbreviated s.c., for the semaglutide injections studied in its main treatment phase.[1]
Read definition and research contextT
Time to peak concentration (Tmax)
The time at which a drug's plasma concentration reaches its peak. This is the meaning given to Tmax in the BPC-157 pharmacokinetic tables.[1]
Read definition and research contextTopical
Applied to a surface such as the skin. The copper tripeptide skin study examines a preparation applied to skin samples.[1]
Read definition and research contextTreatment withdrawal
Stopping the study intervention. In the STEP 1 extension, withdrawal means that the trial's semaglutide or placebo treatment was discontinued.[1]
Read definition and research contextTripeptide
A peptide containing three amino-acid units. GHK refers to glycyl-L-histidyl-L-lysine; GHK-Cu is its copper complex in the cited skin-penetration study.[1]
Read definition and research context